AstraZeneca PLC (AZN) stock
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
AstraZeneca's shares outstanding was 1.56B at Jun 30, 2026. For fiscal 2025 it was 1.56B, down 0.1% from the year before. Over ten years it grew 2.1% a year on average. The highest annual figure on record is 1.56B in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.56B | -0.1% |
| FY2024 | Dec 31, 2024 | 1.56B | +0.1% |
| FY2023 | Dec 31, 2023 | 1.56B | +0.1% |
| FY2022 | Dec 31, 2022 | 1.56B | +9.3% |
| FY2021 | Dec 31, 2021 | 1.43B | +8.7% |
| FY2020 | Dec 31, 2020 | 1.31B | +0.9% |
| FY2019 | Dec 31, 2019 | 1.30B | +2.7% |
| FY2018 | Dec 31, 2018 | 1.27B | 0.0% |
| FY2017 | Dec 31, 2017 | 1.27B | +0.1% |
| FY2016 | Dec 31, 2016 | 1.27B | +0.1% |
| FY2015 | Dec 31, 2015 | 1.26B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 1.56B | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 1.56B | +18.3% |
| Q2 FY2024 | Jun 30, 2024 | 1.56B | +18.8% |
| Q2 FY2023 | Jun 30, 2023 | 1.56B | +18.9% |
| Q2 FY2022 | Jun 30, 2022 | 1.56B | +23.1% |
| Q2 FY2021 | Jun 30, 2021 | 1.32B | +4.0% |
| Q2 FY2020 | Jun 30, 2020 | 1.31B | – |
| Q2 FY2019 | Jun 30, 2019 | 1.31B | – |
| Q2 FY2018 | Jun 30, 2018 | 1.27B | – |
| Q2 FY2017 | Jun 30, 2017 | 1.27B | – |
See a number that looks wrong?